Added 12 days ago Drug news
HALO-301 Phase III study of PEGPH 20 + Abraxane + gemcitabine fails to meet endpoint in pancreatic cancer.- Halozyme Therapeutics
Halozyme Therapeutics announced that the HALO-301 Phase III clinical study evaluating investigational new drug PEGPH20 as a first-line therapy for...
Added 1 month ago Drug news
Lilly announces phase III SEQUOIA study of pegilodecakin + FOLFOX in patients with metastatic pancreatic cancer did not meet primary endpoint of overall survival.
Eli Lilly and Company announced top-line results from its Phase III SEQUOIA trial evaluating pegilodecakin plus FOLFOX (folinic acid, 5-FU,...
Added 3 months ago Drug news
Interim data from an ongoing investigator-sponsored clinical trial led by Baylor College of Medicine evaluating MultiTAA T cell therapy in patients with pancreatic adenocarcinoma.
Marker Therapeutics, Inc. announced interim data from an ongoing investigator-sponsored clinical trial led by Baylor College of Medicine , evaluating...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Fibrinogen is important for blood clot formation and breakdown. It is the first coagulant factor to be reduced to critical levels during massive trauma, cardiac surgery and postpartum haemorrhage that involve excessive bleeding. Persistent fibrinogen deficiency can lead to bleeding complications and an increased risk in mortality. This learning zone looks at both congenital and acquired fibrinogen deficiencies including indications and techniques for diagnosis, trigger level for treatment and treatment options.
The Inflammatory Bowel Disease (IBD) Knowledge Centre contains key information relating to the epidemiology and pathophysiology of Crohn’s disease and ulcerative colitis, highlighting prevalence, impact and unmet needs and the underlying inflammatory processes that drive IBD, considering some of the key inflammatory pathways.
'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.
Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.
This guideline covers diagnosing and managing pancreatic cancer in adults aged 18 and over. It aims to improve care by ensuring quicker and more accurate diagnosis, and by specifying the most effective treatments...
Added 1 year ago
A recent study within Europe reports that pancreatic cancer is the fourth most fatal cancer in men after lung, colorectal, and prostate cancers, and also the fourth most fatal cancer in women after breast, colorectal and lung cancers.
Added 4 years ago
Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Neuroendocrine gastroenteropancreatic tumors (GEP-NETs) constitute a heterogeneous group of tumors with their origin in neuroendocrine cells of the embryological gut. This guideline focuses on diagnosis and pathology/molecular biology...
Added 7 years ago
Efficacy and Safety of Sunitinib in Patients With Well-Differentiated Pancreatic Neuroendocrine Tumours.
Background: In a phase III study, sunitinib led to a significant increase in progression- free survival (PFS) vs. placebo in patients with pancreatic neuroendocrine tumours (panNETs).
Added 1 year ago
Pancreaticoduodenectomy (PD) remains a morbid procedure. The use of Enhanced Recovery After Surgery (ERAS) pathways has proven to reduce care time and post-operative complications after colorectal surgery.
Added 1 year ago
Background: Later weekday of surgery seems to affect the prognosis adversely in oesophageal cancer, whereas any such influence on other cancer sites is unknown. This study aimed to test whether weekday of surgery influenced...
Added 2 years ago
Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more
Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.